22 May 2013
Keywords: Ariad, Merck & Co, Ridaforolimus, Revised collaboration, Sarcoma
Article | 17 March 2010
Cambridge, Massachusetts-based Ariad says it is engaged in advanced negotiations with US drug giant Merck & Co regarding the terms ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2010
21 May 2013
© 2013 thepharmaletter.com